We are live on ! Find out more
QT

Quantbot Technologies Portfolio holdings

AUM $2.44B
1-Year Est. Return 17.13%
This Fund
S&P 500
This Quarter Est. Return
-5.56%
1 Year Est. Return
+17.13%
3 Year Est. Return
+22.15%
5 Year Est. Return
-1.03%
10 Year Est. Return
+28.04%
AUM
$1.32B
AUM Growth
+$237M
Cap. Flow
+$374M
Cap. Flow %
28.26%
Top 10 Hldgs %
6.13%
Holding
2,276
New
613
Increased
472
Reduced
444
Closed
725

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$8.96M
2
YUM icon
Yum! Brands
YUM
+$8.78M
3
V icon
Visa
V
+$8.73M
4
MMM icon
3M
MMM
+$8.13M
5
IFF icon
International Flavors & Fragrances
IFF
+$7.44M

Top Sells

Rank Stock Value
1
HSY icon
Hershey
HSY
+$9.1M
2
STT icon
State Street
STT
+$6.92M
3
KHC icon
Kraft Heinz
KHC
+$5.7M
4
APH icon
Amphenol
APH
+$5.61M
5
KDP icon
Keurig Dr Pepper
KDP
+$5.6M

Sector Composition

Rank Sector Weight
1 Technology 16.99%
2 Financials 15.27%
3 Consumer Discretionary 11.9%
4 Industrials 11.72%
5 Healthcare 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVIR icon
1526
Atea Pharmaceuticals
AVIR
$380M
$1K ﹤0.01%
245
-1,463
-86% -$11.2K
BLND icon
1527
Blend Labs
BLND
$409M
$1K ﹤0.01%
654
-122,275
-99% -$347K
BRZE icon
1528
Braze
BRZE
$2.39B
$1K ﹤0.01%
+56
New +$2.36K
CRNX icon
1529
Crinetics Pharmaceuticals
CRNX
$8.85B
$1K ﹤0.01%
+99
New +$2.02K
CSWC icon
1530
Capital Southwest
CSWC
$1.46B
$1K ﹤0.01%
100
-11,854
-99% -$228K
MIR icon
1531
Mirion Technologies
MIR
$4.13B
$1K ﹤0.01%
244
-4,926
-95% -$34.7K
TSHA icon
1532
Taysha Gene Therapies
TSHA
$1.68B
$1K ﹤0.01%
829
HARP
1533
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1K ﹤0.01%
160
-200
-56% -$3.73K
RUBY
1534
DELISTED
Rubius Therapeutics, Inc
RUBY
$1K ﹤0.01%
4,400
-11,800
-73% -$8.85K
STRY
1535
DELISTED
Starry Group Holdings, Inc.
STRY
$1K ﹤0.01%
+1,299
New +$3.69K
ABCB icon
1536
Ameris Bancorp
ABCB
$6B
-1,028
Closed -$41K
ABNB icon
1537
Airbnb
ABNB
$81.6B
-11,099
Closed -$988K
ABSI icon
1538
Absci
ABSI
$1.37B
-17,234
Closed -$57K
ACAD icon
1539
Acadia Pharmaceuticals
ACAD
$4.25B
-20,294
Closed -$285K
ACB
1540
Aurora Cannabis
ACB
$167M
-13,910
Closed -$183K
ACVA icon
1541
ACV Auctions
ACVA
$1.32B
-106,320
Closed -$695K
ADAP
1542
DELISTED
Adaptimmune Therapeutics
ADAP
-2,000
Closed -$3K
ADSK icon
1543
Autodesk
ADSK
$43.3B
-8,038
Closed -$1.38M
AEE icon
1544
Ameren
AEE
$31.3B
-24,997
Closed -$2.26M
AEG icon
1545
Aegon
AEG
$13.4B
-32,660
Closed -$139K
AFYA icon
1546
Afya
AFYA
$1.26B
-1,900
Closed -$18K
AJG icon
1547
Arthur J. Gallagher & Co
AJG
$62.2B
-6,929
Closed -$1.13M
AKAM icon
1548
Akamai
AKAM
$17.1B
-24,211
Closed -$2.21M
AKRO
1549
DELISTED
Akero Therapeutics
AKRO
-10,100
Closed -$95K
AL
1550
DELISTED
Air Lease Corp
AL
-5,640
Closed -$188K

Similar funds

Quantbot Technologies's Q3 2022 Portfolio in Review

As of Q3 2022, Quantbot Technologies held 2,276 positions worth $1.32B, up 22% from $1.09B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Quantbot Technologies deployed $374M of net new capital in Q3 2022, opening 613 new positions and adding to 472 existing holdings. Its largest new stake was Yum! Brands: 75,600 shares worth $8.04M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was State Street, an estimated $6.92M trimmed.

  • Quantbot Technologies's largest Q3 2022 buy was Yum! Brands: 75,600 shares worth $8.04M.
  • Quantbot Technologies added most to Comcast in Q3 2022, an estimated $8.96M increase.
  • Quantbot Technologies's biggest Q3 2022 reduction was State Street, cutting an estimated $6.92M.
  • Quantbot Technologies fully exited Hershey in Q3 2022, selling an estimated $9.1M.
  • Quantbot Technologies's ten largest holdings make up 6.1% of its $1.32B portfolio in Q3 2022.
  • Quantbot Technologies opened 613 new positions and closed 725 in Q3 2022.
  • Quantbot Technologies's portfolio value rose 22% quarter-over-quarter to $1.32B.

Based on Quantbot Technologies's 13F filing for Q3 2022, filed 7 Nov 2022.